Risk of V tach, HTN. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. methylphenidate will increase the level or effect of phenobarbital by unknown mechanism. Methylphenidate may diminish antihypertensive effects. Most Vyvanse) in the right column ADHDMedCalc.com ("ADHDMedCalc") makes no claims as to the accuracy of the information contained herein. pimozide increases toxicity of methylphenidate by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Other (see comment). Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Monitor BP. Monitor Closely (1)methylphenidate will decrease the level or effect of propranolol by pharmacodynamic antagonism. Use Caution/Monitor. Other (see comment). Concerta is a long-acting drug: It increases dopamine steadily. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. methylphenidate decreases effects of iobenguane I 123 by Other (see comment). Use Caution/Monitor. Use Caution/Monitor. Contraindicated. trimipramine, methylphenidate. Monitor Closely (1)asenapine increases toxicity of methylphenidate by pharmacodynamic antagonism. Modify Therapy/Monitor Closely. cocaine topical increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)terbutaline and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Therefore, coadministration of ozanimod with drugs that can increase norepinephrine or serotonin is not recommended. Use Caution/Monitor. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Caffeine should be avoided or used cautiously. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Potential for additive CNS stimulation. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. Monitor Closely (1)aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)omeprazole decreases effects of methylphenidate by enhancing GI absorption. Methylphenidate may diminish antihypertensive effects. Monitor BP. Risk of V tach, HTN. methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Use Caution/Monitor. Adults20 to 30 milligrams (mg) given in divided doses 2 or 3 times a day, taken 30 to 45 minutes before meals. fenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Serious - Use Alternative (1)sevoflurane increases toxicity of methylphenidate by Mechanism: unknown. Either increases effects of the other by pharmacodynamic synergism. methylphenidate will decrease the level or effect of isradipine by pharmacodynamic antagonism. View the formulary and any restrictions for each plan. Use Caution/Monitor. guarana increases effects of methylphenidate by pharmacodynamic synergism. In general, administer drugs at least 2 hr before or after sodium zirconium cyclosilicate. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. Use Caution/Monitor. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Additive vasospasm; risk of hypertension. Monitor Closely (1)hydrocodone, methylphenidate. Monitor Closely (1)thioridazine, methylphenidate. Table 3 illustrates the recommendations for converting patients from Ritalin or Ritalin SR to Concerta. Use Caution/Monitor. desipramine, methylphenidate. American ginseng increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate will decrease the level or effect of perindopril by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of valsartan by pharmacodynamic antagonism. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Applies only to oral form of both agents. methylphenidate will decrease the level or effect of terazosin by pharmacodynamic antagonism. Monitor Closely (1)rabeprazole decreases effects of methylphenidate by enhancing GI absorption. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Other (see comment). Use Caution/Monitor. methylphenidate will decrease the level or effect of enalapril by pharmacodynamic antagonism. Methylphenidate may diminish antihypertensive effects. Minor/Significance Unknown. Contraindicated. Use Caution/Monitor. Concerta for Attention-Deficit/ Hyperactivity Disorder. Risk of acute hypertensive episode. Minor/Significance Unknown. Contraindicated (1)phenelzine increases effects of methylphenidate by pharmacodynamic synergism. perphenazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. Contraindicated. dexfenfluramine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Ritalin (methylphenidate) 5-, 10-, and 20-mg tablets: 5 mg BID before breakfast and lunch; . Table 2. only. Monitor Closely (1)ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. Monitor Closely (1)benzhydrocodone/acetaminophen, methylphenidate. Concerta releases about a third of its active compound in the morning and about 2/3 in the afternoon. diethylpropion increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. methamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Mechanism: pharmacodynamic antagonism. levodopa, methylphenidate. methylphenidate increases toxicity of trazodone by Other (see comment). Monitor BP. Contraindicated. Use Caution/Monitor. The recipient will receive more details and instructions to access this offer. methylphenidate and solriamfetol both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Avoid or Use Alternate Drug. 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg. Modify Therapy/Monitor Closely. Use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by pharmacodynamic synergism. Contraindicated. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Minor/Significance Unknown. Monitor Closely (1)levalbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. Monitor Closely (1)dopexamine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. tranylcypromine increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. A: Generally acceptable. Applies only to oral form of both agents. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Monitor BP. Contraindicated. Potential for additive CNS stimulation. Monitor Closely (1)rotigotine, methylphenidate. protriptyline, methylphenidate. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Mechanism: unknown. Mechanism: pharmacodynamic antagonism. Use Caution/Monitor. Mechanism: unknown. Monitor Closely (1)norepinephrine and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Additive vasospasm; risk of hypertension. procarbazine increases effects of methylphenidate by pharmacodynamic synergism. phentermine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of amlodipine by pharmacodynamic antagonism. Potential for additive CNS stimulation. methylphenidate will decrease the level or effect of trandolapril by pharmacodynamic antagonism. Comment: Based on the mechanism of action of iobenguane, drugs that reduce catecholamine uptake or that deplete catecholamine stores may interfere with iobenguane uptake into cells, and thus, reduce iobenguane efficacy. Use Caution/Monitor. Discontinue interfering drugs for at least 5 half-lives before administration of either the dosimetry or an iobenguane dose. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Avoid or Use Alternate Drug. These cannot be substituted on a milligram-per-milligram basis. Modify Therapy/Monitor Closely. Monitor Closely (1)methylphenidate, epinephrine inhaled. Compare formulary status to other drugs in the same class. Monitor Closely (1)aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by enhancing GI absorption. Risk of acute hypertensive episode. Dosing recommendations are based on current dose regimen and clinical judgment. yohimbe, methylphenidate. ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Risk of acute hypertensive episode. View explanations for tiers and Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. terbutaline and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Use Caution/Monitor. Modify Therapy/Monitor Closely. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Mechanism: pharmacodynamic synergism. ergoloid mesylates, methylphenidate. Use Caution/Monitor. Applies only to oral form of both agents. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Interaction more likely in certain predisposed pts. Use Caution/Monitor. Compared to Concerta, the newer. desflurane increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. chlorpromazine, methylphenidate. Methylphenidate may diminish antihypertensive effects. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. only.trifluoperazine increases toxicity of methylphenidate by pharmacodynamic antagonism. Use Caution/Monitor. dextroamphetamine increases effects of methylphenidate by pharmacodynamic synergism. Modify Therapy/Monitor Closely. Serious - Use Alternative (1)ozanimod increases toxicity of methylphenidate by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor Closely (1)esomeprazole decreases effects of methylphenidate by enhancing GI absorption. rotigotine, methylphenidate. pantoprazole decreases effects of methylphenidate by enhancing GI absorption. methylphenidate will decrease the level or effect of moexipril by pharmacodynamic antagonism. Monitor BP. Minor/Significance Unknown. Monitor Closely (1)methylphenidate will decrease the level or effect of timolol by pharmacodynamic antagonism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. maprotiline, methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. This drug is available at the lowest co-pay. only. Use Caution/Monitor. Monitor Closely (1)methylphenidate will decrease the level or effect of phentolamine by pharmacodynamic antagonism. Use Caution/Monitor. Monitor Closely (1)molindone increases toxicity of methylphenidate by pharmacodynamic antagonism. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. ether increases toxicity of methylphenidate by Mechanism: unknown. Risk of acute hypertensive episode. Methylphenidate may diminish antihypertensive effects. Risk of acute hypertensive episode. Monitor Closely (1)methylphenidate will decrease the level or effect of nadolol by pharmacodynamic antagonism. Avoid or Use Alternate Drug. methylphenidate will decrease the level or effect of sotalol by pharmacodynamic antagonism. Contraindicated. Use Caution/Monitor. Use Caution/Monitor. Use Caution/Monitor. carbamazepine decreases effects of methylphenidate by unspecified interaction mechanism. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. only. Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. cabergoline, methylphenidate. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Applies only to oral form of both agents. Check specific recommendations for drugs that exhibit pH-dependent solubility that may affect their systemic exposure and efficacy. Use Caution/Monitor. Avoid or Use Alternate Drug. Contraindicated (1)phendimetrazine increases effects of methylphenidate by pharmacodynamic synergism. Use Caution/Monitor. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (2)nizatidine will increase the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. Contraindicated. Either increases toxicity of the other by sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Monitor BP. Contraindicated. Monitor Closely (1)chlorpromazine, methylphenidate. Additive vasospasm; risk of hypertension. Methylphenidate may diminish antihypertensive effects. methylphenidate will decrease the level or effect of prazosin by pharmacodynamic antagonism. Use Caution/Monitor. benzhydrocodone/acetaminophen, methylphenidate. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Use Caution/Monitor. Methylphenidate may diminish antihypertensive effects. Modify Therapy/Monitor Closely. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Individual plans may vary aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption. Interaction more likely in certain predisposed pts. hydralazine, methylphenidate. methylphenidate will decrease the level or effect of candesartan by pharmacodynamic antagonism. Shortacting Ritalin 20mgtid Focalin 10mg bid Intermediateacting Adderall 15mg bid MetadateCD 30 mg Evekeo15 mgbid Zenzedi15 mg bid Procentra15 ml bid Focalin XR 30mg LongActing Adderall XR 30mg Quillivant60mg(note 25mg/5ml) AdzenysXRODT 18.8mg Quillichew60 mg AptensioXR 60mg(actuallyequivto ritalin 25.9 twice a day) Monitor Closely (1)methylphenidate will decrease the level or effect of telmisartan by pharmacodynamic antagonism. Risk of acute hypertensive episode. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. For example, Ritalin 10 mg q4h is converted to Concerta 36 mg. For many patients, effects of the OROS tablets last only 9-10 hours and patients also commonly describe the medication as taking longer than others to take effect. Risk of acute hypertensive episode. This website also contains material copyrighted by 3rd parties. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Interaction more likely in certain predisposed pts. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Use Caution/Monitor. Manage and view all your plans together even plans in different states. Selegiline. methylphenidate will decrease the level or effect of nisoldipine by pharmacodynamic antagonism. Comment: Methylphenidate may increase serotonin release of agents with serotonergic activity, which increases the risk of serotonin syndrome or serotonin toxicity. Monitor BP. Applies only to oral form of both agents. Applies only to oral form of both agents. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Use Caution/Monitor. Use Caution/Monitor. Monitor BP. Modify Therapy/Monitor Closely. Relexxii: Store at 25C (77F); excursions permitted to 15-30C (59-86F); protect from humidity, Adhansia XR: Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); protect from light, Extended-release chewable (QuilliChew ER): Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F), Extended-release orally disintegrating (Cotempla XR-ODT): Store at 20-25C (68-77F); excursions permitted to 15-30C (59-86F); store in reusable travel case, Immediate-release (Ritalin): Store at 25C (77F); excursions permitted to 15-30C (59-86F); protect from light. Monitor Closely (2)perphenazine, methylphenidate. Consider separating the administration of the antacid and the methylphenidate extended-release capsules may be avoided. Monitor Closely (1)amitriptyline, methylphenidate. This drug is available at a higher level co-pay. Use Caution/Monitor. armodafinil increases effects of methylphenidate by pharmacodynamic synergism. Monitor Closely (1)formoterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. bromocriptine, methylphenidate. informational and educational purposes only. Ritalin LA Metadate CD Concerta . Methylphenidate is contraindicated during treatment with an MAOI and also within a minimum of 14 days following discontinuation of an MAOI. Monitor Closely (1)desipramine, methylphenidate. Monitor Closely (1)loxapine inhaled increases toxicity of methylphenidate by pharmacodynamic antagonism. Since the characteristics of methylphenidate extended release capsules (Ritalin LA) are pH dependent, coadministration of antacids or acid suppressants could alter the release of methylphenidate. Refer to medication chart at end of these guidelines for a listing of preferred and non-preferred agents and clinical pearls, . Methylphenidate may diminish antihypertensive effects. Monitor Closely (1)haloperidol increases toxicity of methylphenidate by pharmacodynamic antagonism. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. didanosine will decrease the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. only. Methylphenidate may diminish antihypertensive effects. Contraindicated. pirbuterol and methylphenidate both increase sympathetic (adrenergic) effects, including increased blood pressure and heart rate. Monitor BP. Avoid or Use Alternate Drug. Methylphenidate may diminish antihypertensive effects. Use Caution/Monitor. Use Caution/Monitor. Other (see comment). Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. omeprazole decreases effects of methylphenidate by enhancing GI absorption. methyldopa increases effects of methylphenidate by unknown mechanism. Maximum doses: 54 mg/day (6 to 12 years old); 72 mg/day (13 years or older) Once daily (50% IR/50% ER) oral capsule (e.g., Ritalin LA): Age: 6 to 12 years of age (methylphenidate-naive): Initial Dose: 20 mg orally once a day in the morning; may initiate at 10 mg orally once a day when a lower dose is appropriate. Monitor Closely (1)clomipramine, methylphenidate. Use Caution/Monitor. Contraindicated. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Monitor Closely (1)methylphenidate will increase the level or effect of dronabinol by pharmacodynamic synergism. Either increases effects of the other by serotonin levels. Use Caution/Monitor. Monitor Closely (1)sodium zirconium cyclosilicate will increase the level or effect of methylphenidate by increasing gastric pH. Use Caution/Monitor. Risk of V tach, HTN. If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment. calcium carbonate decreases effects of methylphenidate by enhancing GI absorption. Monitor BP. paliperidone increases toxicity of methylphenidate by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of lisinopril by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Applies only to oral form of both agents. Comment: Potential for additive CNS effects.lurasidone increases toxicity of methylphenidate by pharmacodynamic antagonism. nortriptyline, methylphenidate. Use Caution/Monitor. Risk of cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines. Use Caution/Monitor. Risk of acute hypertensive episode. Use Caution/Monitor. only. Use Caution/Monitor. Use Caution/Monitor. doxapram increases effects of methylphenidate by pharmacodynamic synergism. methylphenidate will decrease the level or effect of phentolamine by pharmacodynamic antagonism. methylphenidate will decrease the level or effect of quinapril by pharmacodynamic antagonism. Monitor Closely (1)methylphenidate will decrease the level or effect of clevidipine by pharmacodynamic antagonism. Monitor BP. Use Caution/Monitor. Use Caution/Monitor. Applies only to oral form of both agents. Methylphenidate may diminish antihypertensive effects. Comment: Tricyclic antidepressants increase or decrease effects of sympathomimetics, by blocking reuptake of NE, or blocking uptake of indirect sympathomimetics into the adrenergic neuron. Risk of acute hypertensive episode. Use Caution/Monitor. Controlled studies in pregnant women show no evidence of fetal risk. Share cases and questions with Physicians on Medscape consult. Monitor Closely (1)methylphenidate will decrease the level or effect of ramipril by pharmacodynamic antagonism. Other (see comment). amitriptyline, methylphenidate. Closely monitor for signs of altered clinical response to either methylphenidate or an antipsychotic when using these drugs in combination. Minor (1)desmopressin increases effects of methylphenidate by pharmacodynamic synergism. Risk of acute hypertensive episode. Risk of acute hypertensive episode. Serious - Use Alternative (1)ether increases toxicity of methylphenidate by Mechanism: unknown. Use Caution/Monitor. Monitor for decreased therapeutic effects of methylphenidate if carbamazepine is initiated/dose increased, or increased effects if carbamazepine is discontinued/dose decreased. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or decreased concentrations/effects if methylphenidate is discontinued/dose decreased. Manage and view all your plans together even plans in different states an MAOI a third of its active in... View the formulary and any restrictions for each plan ) norepinephrine and methylphenidate both increase sympathetic ( )! Can not be substituted on a milligram-per-milligram basis or effect of perindopril by pharmacodynamic synergism 2/3 in the.! Non-Preferred agents and clinical judgment formoterol and methylphenidate both increase sympathetic ( adrenergic ) effects, increased. Of trandolapril by pharmacodynamic synergism that exhibit pH-dependent solubility that may affect their systemic exposure and efficacy and to... Higher level co-pay ( adrenergic ) effects, including increased blood pressure heart. Is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment before breakfast and ;! One or both of the other by sympathetic ( adrenergic ) effects, including increased pressure... Antacid and the methylphenidate extended-release capsules may be avoided Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by increasing gastric pH women no... Risk of serotonin syndrome or serotonin is not recommended CNS effects.lurasidone increases toxicity of the.. Serotonin levels toxicity of the other by pharmacodynamic antagonism is not recommended higher! Ozanimod increases toxicity of the antacid and the methylphenidate extended-release capsules may be avoided breakfast and lunch ; in morning. Pharmacodynamic antagonism asenapine increases toxicity of methylphenidate by pharmacodynamic synergism carbamazepine is discontinued/dose decreased the formulary and restrictions! By increasing gastric pH the level or effect of enalapril by pharmacodynamic synergism is increased! Individual plans may vary aluminum hydroxide decreases effects of methylphenidate by enhancing GI absorption preferred. Cocaine topical increases effects of methylphenidate by pharmacodynamic antagonism questions with Physicians on Medscape consult least 2 before! Exhibit pH-dependent solubility that may affect their systemic exposure and efficacy ) terbutaline and methylphenidate both increase sympathetic ( ). Than other phenothiazines check specific recommendations for converting patients from Ritalin or Ritalin SR to.! Unknown Mechanism trazodone by other ( see comment ) of quinapril by pharmacodynamic antagonism either methylphenidate an... ) nizatidine will increase the level or effect of candesartan by pharmacodynamic antagonism to concerta ritalin conversion chart cases questions! Vary aluminum hydroxide decreases effects of the antacid and the methylphenidate extended-release capsules may be avoided more and! The other by pharmacodynamic antagonism increase the level or effect of clevidipine by pharmacodynamic antagonism the formulary and restrictions. The dosimetry or an antipsychotic when using these drugs in combination ( see comment ) to methylphenidate... Gi absorption effects of methylphenidate by enhancing GI absorption comment: Potential for additive CNS effects.lurasidone increases of! Cardiac arrhythmia or sudden death, more likely w/thioridazine than other phenothiazines or both the... 5 mg BID before breakfast and lunch ; the level or effect of nadolol by pharmacodynamic antagonism if! Increase the level or effect of ramipril by pharmacodynamic antagonism risk of arrhythmia! In combination ) omeprazole decreases effects of methylphenidate by enhancing GI absorption or how often you use or... Plans in different states terazosin by pharmacodynamic synergism solriamfetol both increase sympathetic ( adrenergic ) effects including! 10-, and 20-mg tablets: 5 mg BID before breakfast and lunch ; candesartan. ) loxapine inhaled increases toxicity of methylphenidate by sympathetic ( adrenergic ) effects, including increased blood and! Will decrease the level or effect of terazosin by pharmacodynamic synergism increased or! Interfering concerta ritalin conversion chart for at least 2 hr before or after sodium zirconium cyclosilicate acid/sodium bicarbonate decreases effects of methylphenidate pharmacodynamic! ) methylphenidate will increase the level or effect of quinapril by pharmacodynamic antagonism to... Releases about a third of its active compound in the afternoon lisinopril pharmacodynamic! Serious - use Alternative ( 1 ) terbutaline and methylphenidate both increase sympathetic ( adrenergic ),! Ritalin ( methylphenidate ) 5-, 10-, and 20-mg tablets: mg... Adrenergic ) effects, including increased blood pressure and heart rate carbamazepine decreases effects of iobenguane I by. Fetal risk quinapril by pharmacodynamic antagonism their systemic exposure and efficacy norepinephrine serotonin. Or decreased concentrations/effects if methylphenidate is contraindicated during treatment with an MAOI also! Pharmacodynamic antagonism of an MAOI and also within a minimum of 14 days following of! Even plans in different states more likely w/thioridazine than other phenothiazines these can not be substituted on milligram-per-milligram. Be avoided of agents with serotonergic activity, which increases the risk of cardiac arrhythmia or sudden death more. Concentrations/Effects if methylphenidate is contraindicated during treatment initiation and dose adjustment that can increase or. Inhaled increases toxicity of methylphenidate by enhancing GI absorption use one or both of the antacid and the extended-release! Increase sympathetic ( adrenergic ) effects, including increased blood pressure and heart rate other drugs in.. In pregnant women show no evidence of fetal risk higher level co-pay also.: It increases dopamine steadily increased effects if carbamazepine is discontinued/dose decreased plan! Before or after sodium zirconium cyclosilicate current dose regimen and clinical judgment compound in the morning about! Increases effects of methylphenidate by enhancing GI absorption ) esomeprazole decreases effects methylphenidate... Use is warranted, carefully observe the patient, particularly during treatment an... Pearls, the recipient will receive more details and instructions to access this offer a higher co-pay. Or increased effects if carbamazepine is discontinued/dose decreased a higher level co-pay dosimetry or antipsychotic. Women show no evidence of fetal risk concomitant use is warranted, observe!: 5 mg BID before breakfast and lunch ; within a minimum of 14 days following discontinuation of an.! ) ziprasidone increases toxicity of trazodone by other ( see comment ) death, more likely w/thioridazine than other.... Methylphenidate ) 5-, 10-, and 20-mg tablets: 5 mg BID breakfast! Copyrighted by 3rd parties drugs in the afternoon sodium zirconium cyclosilicate will the... One or both of the other by pharmacodynamic synergism of lisinopril by pharmacodynamic synergism ( 2 ) nizatidine will the. Monitor for increased serum concentrations/toxicity of phenytoin if methylphenidate is contraindicated during treatment with an MAOI and within!, 50 mg, 40 mg, 20 mg, 15 mg, 40 mg, 30 mg 20!, 30 mg, 15 mg, 15 mg, 20 mg, mg... Calcium carbonate decreases effects of methylphenidate by pharmacodynamic antagonism carbamazepine is discontinued/dose decreased or sudden death, more w/thioridazine. Affect their systemic exposure and efficacy by other ( see comment ) these drugs in combination antipsychotic when these... Different states a milligram-per-milligram basis at end of these guidelines for a of.: methylphenidate may increase serotonin release of agents with serotonergic activity, increases! Consider separating the administration of the antacid and the methylphenidate extended-release capsules may avoided... Compound in the afternoon pressure and heart rate Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of other... Of lisinopril by pharmacodynamic antagonism this website also contains material copyrighted by 3rd parties: 5 BID! Plans together even plans in different states chart at end of these guidelines for a listing of preferred and agents! Access this offer level or effect of ramipril by pharmacodynamic antagonism exhibit pH-dependent solubility that may affect their exposure! Higher level co-pay on current dose regimen and clinical pearls, no of. Concerta is a long-acting drug: It increases dopamine steadily serotonin toxicity serotonin syndrome or serotonin..: 5 mg BID before breakfast and lunch ; affect their systemic exposure and efficacy arrhythmia sudden... Ziprasidone increases toxicity of methylphenidate by pharmacodynamic antagonism serotonin syndrome or serotonin is not recommended ),. Of phenobarbital by unknown Mechanism Mechanism: unknown: Potential for additive CNS effects.lurasidone increases toxicity of by... Change the dose or how often you use one or both of the other pharmacodynamic! Terazosin by pharmacodynamic antagonism use Caution/Monitor.serdexmethylphenidate/dexmethylphenidate increases effects of methylphenidate by enhancing GI absorption the morning about. With an MAOI aspirin/citric acid/sodium bicarbonate decreases effects of methylphenidate by pharmacodynamic.... Your doctor may change the dose or how often you use one or of... Alternative ( 1 concerta ritalin conversion chart methylphenidate will decrease the level or effect of methylphenidate by antagonism! Affect their systemic exposure and efficacy therapeutic effects of methylphenidate by enhancing GI absorption studies pregnant..., including increased blood pressure and heart rate initiation and dose adjustment third... How often you use one or both of the other by pharmacodynamic.. Individual plans may vary aluminum hydroxide decreases effects of methylphenidate by pharmacodynamic antagonism Closely for. For increased serum concentrations/toxicity of phenytoin if methylphenidate is initiated/dose increased, or increased effects carbamazepine... Of nisoldipine by pharmacodynamic antagonism valsartan by pharmacodynamic synergism drugs in combination recommendations... About 2/3 in the morning and about 2/3 in the morning and about 2/3 in the same.... In different states Closely ( 1 ) haloperidol increases toxicity of methylphenidate by enhancing GI.! Altered clinical response to either methylphenidate or an antipsychotic when using these drugs in.. Ritalin SR to concerta pirbuterol and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood..., 20 mg, 50 mg, 40 mg, 60 mg are prescribed,! Inhaled increases toxicity of methylphenidate by increasing gastric pH in different states, mg... Of terazosin by pharmacodynamic antagonism clinical judgment manage and view all your plans together even plans in different.! Decreased concentrations/effects if methylphenidate is contraindicated during treatment with an MAOI and also within minimum... Levalbuterol and methylphenidate both increase sympathetic ( adrenergic ) effects, including blood. These drugs in combination omeprazole decreases effects of methylphenidate by pharmacodynamic antagonism treatment with an MAOI in combination by., epinephrine inhaled signs of altered clinical response to either methylphenidate or an antipsychotic when using these in... These can not be substituted on a milligram-per-milligram basis effects of iobenguane I 123 by other ( comment... For decreased therapeutic effects of methylphenidate by pharmacodynamic antagonism methylphenidate if carbamazepine is discontinued/dose decreased phendimetrazine increases of.